186 related articles for article (PubMed ID: 11249656)
1. Recent developments in mucosal delivery of pDNA vaccines.
Barnes AG; Barnfield C; Brew R; Klavinskis LS
Curr Opin Mol Ther; 2000 Feb; 2(1):87-93. PubMed ID: 11249656
[TBL] [Abstract][Full Text] [Related]
2. DNA vaccines--challenges in delivery.
Pachuk CJ; McCallus DE; Weiner DB; Satishchandran C
Curr Opin Mol Ther; 2000 Apr; 2(2):188-98. PubMed ID: 11249641
[TBL] [Abstract][Full Text] [Related]
3. Novel strategies using DNA for the induction of mucosal immunity.
McCluskie MJ; Davis HL
Crit Rev Immunol; 1999; 19(4):303-29. PubMed ID: 10530431
[TBL] [Abstract][Full Text] [Related]
4. Live attenuated bacteria as vectors to deliver plasmid DNA vaccines.
Dietrich G; Spreng S; Favre D; Viret JF; Guzman CA
Curr Opin Mol Ther; 2003 Feb; 5(1):10-9. PubMed ID: 12669465
[TBL] [Abstract][Full Text] [Related]
5. Oral delivery of micro-encapsulated DNA vaccines.
Jones DH; Clegg JC; Farrar GH
Dev Biol Stand; 1998; 92():149-55. PubMed ID: 9554269
[TBL] [Abstract][Full Text] [Related]
6. Targeting the mucosa: genetically engineered vaccines and mucosal immune responses.
Stevceva L; Abimiku AG; Franchini G
Genes Immun; 2000 Jun; 1(5):308-15. PubMed ID: 11196691
[TBL] [Abstract][Full Text] [Related]
7. The mechanism of naked DNA uptake and expression.
Wolff JA; Budker V
Adv Genet; 2005; 54():3-20. PubMed ID: 16096005
[TBL] [Abstract][Full Text] [Related]
8. Mucosally-administered human-simian immunodeficiency virus DNA and fowlpoxvirus-based recombinant vaccines reduce acute phase viral replication in macaques following vaginal challenge with CCR5-tropic SHIVSF162P3.
Kent SJ; Dale CJ; Ranasinghe C; Stratov I; De Rose R; Chea S; Montefiori DC; Thomson S; Ramshaw IA; Coupar BE; Boyle DB; Law M; Wilson KM; Ramsay AJ
Vaccine; 2005 Oct; 23(42):5009-21. PubMed ID: 15985317
[TBL] [Abstract][Full Text] [Related]
9. Jump-starting the immune system: prime-boosting comes of age.
Woodland DL
Trends Immunol; 2004 Feb; 25(2):98-104. PubMed ID: 15102369
[TBL] [Abstract][Full Text] [Related]
10. Use of attenuated bacteria as delivery vectors for DNA vaccines.
Daudel D; Weidinger G; Spreng S
Expert Rev Vaccines; 2007 Feb; 6(1):97-110. PubMed ID: 17280482
[TBL] [Abstract][Full Text] [Related]
11. Optimization and delivery of plasmid DNA for vaccination.
Jechlinger W
Expert Rev Vaccines; 2006 Dec; 5(6):803-25. PubMed ID: 17184219
[TBL] [Abstract][Full Text] [Related]
12. Intramuscular delivery of a cholera DNA vaccine primes both systemic and mucosal protective antibody responses against cholera.
Xu G; Wang S; Zhuang L; Hackett A; Gu L; Zhang L; Zhang C; Wang H; Huang Z; Lu S
Vaccine; 2009 Jun; 27(29):3821-30. PubMed ID: 19443090
[TBL] [Abstract][Full Text] [Related]
13. Current status and future perspectives of DNA vaccine delivery by attenuated intracellular bacteria.
Dietrich G
Arch Immunol Ther Exp (Warsz); 2000; 48(3):177-82. PubMed ID: 10912622
[TBL] [Abstract][Full Text] [Related]
14. DNA vaccines: vector design, delivery, and antigen presentation.
Feltquate DM
J Cell Biochem Suppl; 1998; 30-31():304-11. PubMed ID: 9893284
[TBL] [Abstract][Full Text] [Related]
15. DNA-loaded biodegradable microparticles as vaccine delivery systems and their interaction with dendritic cells.
Jilek S; Merkle HP; Walter E
Adv Drug Deliv Rev; 2005 Jan; 57(3):377-90. PubMed ID: 15560947
[TBL] [Abstract][Full Text] [Related]
16. The cellular basis of immune induction at mucosal surfaces by DNA vaccination.
Barnfield C; Brew R; Tilling R; Rae A; Wheeler C; Klavinskis LS
Dev Biol (Basel); 2000; 104():159-64. PubMed ID: 11713815
[TBL] [Abstract][Full Text] [Related]
17. Bacterial ghosts as adjuvant particles.
Riedmann EM; Kyd JM; Cripps AW; Lubitz W
Expert Rev Vaccines; 2007 Apr; 6(2):241-53. PubMed ID: 17408373
[TBL] [Abstract][Full Text] [Related]
18. Bacterial vectors and delivery systems in cancer therapy.
Gardlik R; Fruehauf JH
IDrugs; 2010 Oct; 13(10):701-6. PubMed ID: 20878592
[TBL] [Abstract][Full Text] [Related]
19. The efficiency of a novel delivery system (PEI600-Tat) in development of potent DNA vaccine using HPV16 E7 as a model antigen.
Bolhassani A; Ghasemi N; Servis C; Taghikhani M; Rafati S
Drug Deliv; 2009 May; 16(4):196-204. PubMed ID: 19514980
[TBL] [Abstract][Full Text] [Related]
20. A study of systems for delivering antigens and plasmid DNA for intranasal immunization against tick-borne encephalitis virus.
Goncharova EP; Ryzhikov AB; Bulychev LE; Sizov AA; Lebedev LR; Poryvaev VD; Karpenko LI; Il'ichev AA
Wien Klin Wochenschr; 2002 Jul; 114(13-14):630-5. PubMed ID: 12422616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
